Zobrazeno 1 - 10
of 127
pro vyhledávání: '"Eacho P"'
Autor:
Eacho, Rebecca (Ormiston)
Publikováno v:
Eugene O'Neill Review (Project Muse); October 2024, Vol. 45 Issue: 2 p188-193, 6p
Autor:
Krista M. Schroeder, Thomas P. Beyer, Ryan J. Hansen, Bomie Han, Richard T. Pickard, Victor J. Wroblewski, Mark C. Kowala, Patrick I. Eacho
Publikováno v:
Journal of Lipid Research, Vol 56, Iss 11, Pp 2124-2132 (2015)
Lilly PCSK9 antibody LY3015014 (LY) is a monoclonal antibody (mAb) that neutralizes proprotein convertase subtilisin-kexin type 9 (PCSK9). LY decreases LDL cholesterol in monkeys and, unlike other PCSK9 mAbs, does not cause an accumulation of intact
Externí odkaz:
https://doaj.org/article/f9915123339b461b9a86c49a1bb6065e
Autor:
Bomie Han, Patrick I. Eacho, Michael D. Knierman, Jason S. Troutt, Robert J. Konrad, Xiaohong Yu, Krista M. Schroeder
Publikováno v:
Journal of Lipid Research, Vol 55, Iss 7, Pp 1505-1514 (2014)
Proprotein convertase subtilisin-kexin type 9 (PCSK9) is a secreted protein which regulates serum LDL cholesterol. It circulates in human and rodent serum in an intact form and a major truncated form. Previous in vitro studies involving the expressio
Externí odkaz:
https://doaj.org/article/c418d74c90224ffda7dbe266040357e4
Autor:
Yue-Wei Qian, Robert J. Schmidt, Youyan Zhang, Shaoyou Chu, Aimin Lin, He Wang, Xiliang Wang, Thomas P. Beyer, William R. Bensch, Weiming Li, Mariam E. Ehsani, Deshun Lu, Robert J. Konrad, Patrick I. Eacho, David E. Moller, Sotirios K. Karathanasis, Guoqing Cao
Publikováno v:
Journal of Lipid Research, Vol 48, Iss 7, Pp 1488-1498 (2007)
Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a protease that regulates low density lipoprotein receptor (LDLR) protein levels. The mechanisms of this action, however, remain to be defined. We show here that recombinant human PCSK9 express
Externí odkaz:
https://doaj.org/article/e83e1b4f8a864a4c80a2187d406a793c
Autor:
Robert J. Schmidt, James V. Ficorilli, Youyan Zhang, Kelli S. Bramlett, Thomas P. Beyer, Kristen Borchert, Michele S. Dowless, Keith A. Houck, Thomas P. Burris, Patrick I. Eacho, Guosheng Liang, Li-wei Guo, William K. Wilson, Laura F. Michael, Guoqing Cao
Publikováno v:
Journal of Lipid Research, Vol 47, Iss 5, Pp 1037-1044 (2006)
Hypercholesterolemia is a major risk factor for coronary artery disease. Oxysterols are known to inhibit cholesterol biosynthesis and have been explored as potential antihypercholesterolemic agents. The ability of 3β-hydroxy-5α-cholest-8(14)-en-15-
Externí odkaz:
https://doaj.org/article/dde7296348914bc195be72f807c06492
Autor:
Eacho, Douglas
Publikováno v:
Theatre & Performance Design; April 2023, Vol. 9 Issue: 1-2 p20-36, 17p
Autor:
Daniel R. Jones, Robert J. Schmidt, Richard T. Pickard, Patricia S. Foxworthy, Patrick I. Eacho
Publikováno v:
Journal of Lipid Research, Vol 43, Iss 3, Pp 383-391 (2002)
Estrogen replacement therapy in women decreases hepatic lipase (HL) activity, which may account for the associated increase in HDL cholesterol. To investigate whether estrogen decreases HL transcription, transient cotransfection assays with HL promot
Externí odkaz:
https://doaj.org/article/8ca3c86fe334480e80531804c268c4c2
Publikováno v:
Journal of Lipid Research, Vol 41, Iss 9, Pp 1390-1401 (2000)
Our studies were conducted to explore the role of hepatic fatty acid-binding protein (L-FABP) in fatty acid transport to the nucleus. Purified rat L-FABP facilitated the specific interaction of [3H]oleic acid with the nuclei. L-FABP complexed with un
Externí odkaz:
https://doaj.org/article/dfefc0b5949849a2902b9e1647b120e1
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.